Titrated Oral Misoprostol Solution Versus Intravenous Oxytocin for Augmentation of Labour

Authors

  • Umbreen Idrees
  • Sara Ali
  • Ayaz Ahmed
  • Sajjad Sabir
  • Ammarah Saeed

Keywords:

Augmentation of labour, Intravenous oxytocin, Titrated oral Misoprostol.

Abstract

Objective:To compare the efficacy of titrated oral mis oprostol solution with intravenous oxytocin for augmentation
of labour in term primigravidae in active phase of labour with inadequate uterine contractions.
Methodology:This randomized control trial was conducted in the department of Gynaecology and Obstetrics, Pakistan
Institute of Medical Sciences, Islamabad, over a period of six months from 14-April to 13-October, 2014.
A total of 760 (two groups of 380 each) primigravidae, between age 20-39 years, who had completed 37-42 gestational
weeks by dates, or by ultrasound scan, with regular contractions and an effaced cervix dilated between 3-4 cm, and who
later developed inadequate uterine contractions during the first stage of labour were included in the study. Group A
received titrated oral misoprostol solution 200μg tablet dissolved in 200ml tap water and 20ml (20μg/hour) and
group-B was given Intravenous oxytocin (10 units in 1000cc Hartman’s solution at 8 drops/minute, doubling every
30 minutes up to a maximum of 64 drops/min for 2 hours).
Results: Mean (±SD) age of the patients was 26.4±4.4 and 26.6±4.6 years in group-A and B respectively. In
group-A, 322 patients (84.7%) and in group-B 326 patients (85.8%) were delivered vaginally. Mean (±SD)
augmentation to delivery interval was 293.82±99.36 and 311.65±106.73 minutes in group-A and B respectively.
Mean (±SD) gestational age in group-A was 38.82±1.32 and in group-B 38.83±1.09 week. Caesarean section was
performed in rest of the patients in both groups. There was no significant association between mode of delivery
in both groups (P-value= 0.682).
Conclusion:Labour augmentation with titrated oral misoprostol or intravenous oxytocin resulted in about similar
rates of vaginal delivery.

References

Wei S, Wo BL, Xu H, Luo ZC, Roy C, Fraser WD. Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care. The Cochrane database of systematic reviews. 2009;2(2):CD006794

Ho M, Cheng SY, Li TC. Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics and Gynecology 2010;116(3):612-8

Syed S, Chaudhri R, Rizvi F, Afzal M. Oral misopros- tol for induction of labour. Journal of the College of Physicians and Surgeons-Pakistan 2010;20 (2):102- 5

Malik HZ, Khawaja NP, Zahid B, Rehman R. Subling- ual versus oral misoprostol for induction of labour in prelabour rupture of membranes at term. Journal of the College of Physicians and Surgeons-Pakistan 2010;20(4):242-5

Bohra U, Donnelly J, O'Connell MP, Geary MP, Mac Quillan K, Keane DP. Active management of labour revisited: the first 1000 primiparous labours in 2000. Obstetrics and Gynecology 2003;23(2):118-20

Naqvi SB, Haroon ZUN. Efficacy and safety of drotaverine and phloroglucinol in first stage of labour. Pak J Surg 2011;27(1):39-43

Tahir S, Liaqat M, Jabeen S. Effectiveness of Phloroglucinol to accelerate labor in Primigravidas at term: Double blind, randomized controlled trial PJMHS 2015;9(1):169-73

Tabassum S, Afridi B, Aman Z. Phloroglucinol for acceleration of labour: double blind, randomized controlled trial. The Journal of the Pakistan Medical Association 2005;55(7):270-3

Wei SQ, Luo ZC, Qi HP, Xu H, Fraser WD. High- dose vs low-dose oxytocin for labor augmentation: a systematic review. American journal of obstetrics and gynecology 2010;203(4):296-304

Singh KC, Jain P, Goel N, Saxena A. Drotaverine hydrochloride for augmentation of labor. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2004;84(1):17-22

Betran AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van Look P, et al. Rates of caesarean section: analysis of global, regional and national estimates. Paediatric and perinatal epidemiology. 2007;21(2):98-113

Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR. The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990-2014. PloS one 2016;11(2):e0148343

O'Driscoll K, Foley M, MacDonald D. Active management of labour as an alternative to cesarean section for dystocia. Obstetrics and gynecology 1984;63(4):485-90

Jamal A, Kalantari R. High and low dose oxytocin in augmentation of labor. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2004;87(1):6-8

Wing DA, Fassett MJ, Guberman C, Tran S, Parrish A, Guinn D. A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations. American journal of obstetrics and gynecology. 2004;190(6):1689-94; discussion 94-6

Cheng SY, Ming H, Lee JC. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics and gyneco- logy 2008;111(1):119-25

Sadaf M, Sial SS, Malik SN. Augmentation of Labour- A Comparison of Oral Misoprostol and Intravenous Titrated Oxytocin Infusion. JRMC 2013;17(2):247- 50

Aalami-Harandi R, Karamali M, Moeini A. Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia-e-Obstetricia 2013;35(2):60-5

Asokan KM, Santhosh S. Comparative Study of Titrated Oral Misoprostol Solution and Oxytocin to Induce Labour Conducted at Kannur Medical College. IJSS 2016;3(11):255-58

Bleich AT, Villano KS, Lo JY, Alexander JM, McIntire DD, Leveno KJ. Oral misoprostol for labor augmentation: a randomized controlled trial. Obstet Gynecol 2011;118(6):1255-60

Windrim R, Benett K, Mundle W. Oral administration of misoprostol for labour induction: a randomized controlled trial. Obstet Gynecol 1998;89:392-7

Nigam A, Singh V, Dubay P, Pandey K, Bhagoliwal A, Prakash A. Misoprostol vs. oxytocin for induction of labor at term. Int J Gyn Obst 2004;86(3):398-400

de Aquino MM, Cecatti JG. Misoprostol versus oxytocin for labor induction in term and post-term pregnancy: randomized controlled trial. Sao Paulo medical journal = Revista paulista de medicina 2003;121(3):102-6

Kremer RL, Gilson GJ, Morrison DS, Martin D, Gonzales JL, Qualls CR. A randomized trial of misoprostol and Oxytocin for induction of labour: Safety and efficaly Obstet Gynecol 1997; 89 (3):387- 91

Shaheen RS, Sharma R, Mathur A. Comparative Study of Low Dose Vaginal Misoprostol versus Oxytocin in Induction of Labor. J SAFOG 2010;2(3):193-5

Downloads

Published

2017-03-06

How to Cite

Idrees, U. ., Ali, S. ., Ahmed, A. ., Sabir, S. ., & Saeed, A. . (2017). Titrated Oral Misoprostol Solution Versus Intravenous Oxytocin for Augmentation of Labour. Journal of Bahria University Medical and Dental College, 7(1), 24–27. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/222

Issue

Section

Original Articles